Former Names NOD.NON-H2g (Changed: 15-DEC-04 ) Type Congenic; Major Histocompatibility Congenic; Mutant Strain; Additional information on Genetically Engineered and Mutant Mice. Visit our online Nomenclature tutorial. Additional information on Congenic nomenclature. Species laboratory mouse Background Strain NON/ShiLt Donor Strain NOD/ShiLt Generation N21F54p+F6 (05-DEC-11)
Generation DefinitionsAppearance
albino
Related Genotype: A/A Tyrp1b/Tyrp1b Tyrc/TyrcDescription
This histocompatibility congenic strain carries the diabetogenic MHC from NOD/ShiLtJ mice and is used as a comparison strain for NOD/ShiLtJ (Stock No. 001976) and NON/ShiLtJ (Stock No. 002423). These mice exhibit some but not all of the immune dysfunctions of NOD/ShiLtJ mice. These mice are useful for dissecting the role of MHC versus non-MHC genes in producing aberrant immunophenotypes.
| Control | ||
|---|---|---|
| 002423 NON/ShiLtJ | ||
| Considerations for Choosing Controls | ||
Strains carrying H2g7 allele
003851 ALR.NOD-(D17Mit30-D17Mit123)/Lt 010972 B10.NOD-(rs13459151-rs13483054)/1107MrkJ 005717 B6(NOD) H2g7-Sostdc1shk/GrsrJ 005715 B6.Cg H2g7-Tg(Ins2-CD80)3B7Flv/LwnJ 003068 B6.NOD-(Csf2-D11Mit42) (D17Mit21-D17Mit10)/J 004554 B6.NOD-(D17Mit21-D17Mit10) Tg(TCRaAI4)1Dvs/DvsJ 004555 B6.NOD-(D17Mit21-D17Mit10) Tg(TCRbAI4)1Dvs/DvsJ 003300 B6.NOD-(D17Mit21-D17Mit10)/LtJ 003069 B6.NOD-(D1Mit3-Bcl2) (D17Mit21-D17Mit10)/LtJ 003071 B6.NOD-(D1Mit5.1-D1Mit15) (D17Mit21-D17Mit10)/J 003067 B6.NOD-(D3Mit132-Tshb) (D17Mit21-D17Mit10)/J 003066 B6.NOD-(D6Mit54-D6Mit14) (D17Mit21-D17Mit10)/J View Strains carrying H2g7 (12 strains)
Strains carrying other alleles of H2
006500 129.NOD-(D17Mit175-H2)/J 001649 A.BY H2bc H2-T18f/SnJ-Dstncorn1/J 000140 A.BY-H2bc H2-T18f/SnJ 000472 A.CA-H2f H2-T18a/SnJ 000471 A.SW-H2s H2-T18b/SnJ 001066 A.TH-H2t2/SfDvEgMobJ 001067 A.TL-H2t1/SfDvEgMobJ 002089 AK.B6-H2b Fv1b/J 002090 AK.B6-H2b/J 001094 AK.L-H2b/1CyTyJ 001095 AK.L-H2oz2/CyJ 001096 AK.L-H2oz3/CyJ 000470 AK.M-H2m H2-T18a/nSnJ 000469 B10.A-H2a H2-T18a/SgSnJ 000468 B10.A-H2h2/(2R)SgSnJ 001150 B10.A-H2h4/(4R)SgDvEgJ 001149 B10.A-H2i3/(3R)SgDvEgJ 000467 B10.A-H2i5 H2-T18a/(5R)SgSnJ 000466 B10.AKM-H2m H2-T18a/SnJ 001954 B10.AQR-H2y1/KljMcdJ 000465 B10.BR-H2k2 H2-T18a/SgSnJ 004804 B10.BR-H2k2 H2-T18a/SgSnJJrep 005308 B10.Cg-H2d Tg(TcraCl4,TcrbCl4)1Shrm/ShrmJ 005534 B10.Cg-H2d Tg(Ins2-HA)165Bri/ShrmJ 010514 B10.Cg-H2g Tg(Cd4-Klra1)6295Dl/J 006446 B10.Cg-H2h4 Sh3pxd2bnee/GrsrJ 006102 B10.Cg-H2k Tg(Il2/NFAT-luc)83Rinc/J 006100 B10.Cg-H2k Tg(NFkB/Fos-luc)26Rinc/J 005895 B10.Cg-Thy1a H2d Tg(TcraCl1,TcrbCl1)1Shrm/J 002024 B10.D1-H2q/SgJ 001163 B10.D2-H2bm23/EgJ 000462 B10.D2-H2d/n2SnJ 001164 B10.D2-H2dm1/EgJ 001151 B10.D2-H2g3/(103R)EgJ 001153 B10.D2-H2i7/(107R)EgJ 001152 B10.D2-H2ia/(106R)EgJ 000460 B10.D2-Hc0 H2d H2-T18c/o2SnJ 000461 B10.D2-Hc0 H2d H2-T18c/oSnJ 000463 B10.D2-Hc1 H2d H2-T18c/nSnJ 003147 B10.D2-Hc1 H2d H2-T18c/nSnJ-Tg(DO11.10)10Dlo/J 000464 B10.DA-H2qp1 H2-T18b/(80NS)SnJ 001823 B10.F-H2bp5/(14R)J 001818 B10.F-H2pb1/(13R)J 001012 B10.HTG-H2g/2CyJ 000999 B10.HTG-H2g/3CyJ 001894 B10.LG-H2ar1/J 000459 B10.M-H2f H2-T18a?/SnJ 002225 B10.M-H2f/nMob Fmn1ld-2J/J 001068 B10.M-H2f/nMobJ 000739 B10.M-H2fm2/MobJ 001154 B10.MBR-H2bq1/SxEgJ 001825 B10.P-H2kp1/(10R)SgJ 003199 B10.PL-H2u H2-T18a/(73NS)Sn-Tg(TCRA)B1Jg/J 003200 B10.PL-H2u H2-T18a/(73NS)Sn-Tg(TCRB)C14Jg/J 000458 B10.PL-H2u H2-T18a/(73NS)SnJ 000457 B10.RIII-H2r H2-T18b/(71NS)SnJ 001069 B10.RIII-H2r/(71NS)nMobJ 001760 B10.S-H2as1/(8R)/J 001953 B10.S-H2s/SgMcdJ 001817 B10.S-H2sm1/(12R)SgJ 001650 B10.S-H2t4/(9R)/J 000456 B10.SM H2v H2-T18b/(70NS)Sn-cw/J 001155 B10.T-H2y2/(6R)SgDvEgJ 000445 B10.WB-H2j H2-T18b/SnJ 000444 B10.Y-H2pa H2-T18c/SnJ 003483 B6 x B10.D1-H2q/SgJ-Nox3het-2J/J 003561 B6 x B10.PL-H2u/(73NS)Sn-Hxl/J 002995 B6 x C.B10-H2b/LiMcdJ-Fbn2fp-2J/J 003584 B6.129S2-H2dlAb1-Ea/J 001148 B6.AK-H2k/FlaEgJ 001895 B6.AK-H2k/J 001160 B6.C-H2bm10/KhEgJ 001161 B6.C-H2bm11/KhEgJ 000364 B6.C-H2bm2/ByJ 000369 B6.C-H2bm4/ByJ 001158 B6.C-H2bm7/KhEgJ 000360 B6.C-H2d Mdmg1BALB/cBy/aByJ 000359 B6.C-H2d/bByJ 001429 B6.C-H2g6/J 007958 B6.Cg-H2b3/FlaCmwJ 007959 B6.Cg-H2b4/FlaCmwJ 000944 B6.SJL-H2b C3c/2CyJ 000966 B6.SJL-H2s C3c/1CyJ 000945 B6.SW/1CyJ 003374 B6;129S2-H2dlAb1-Ea/J 003240 B6;B10.A-H2a-Tg(H2KmPCC)2939Stoe/J 002844 BALB.5R-H2i5/LilJ 001165 BALB/c-H2dm2/KhEgJ 001041 BKS.B6-H2b/J 001892 BRVR.B10-H2b/J 001893 BRVR.D2-H2d/J 002845 C.B-H2b Tg(H2-Dd)D8Gja/LilJ 001952 C.B10-H2b/LilMcdJ 001768 C3.Cg-Irs1Sml H2b/GrsrJ 000443 C3.HTG-H2g H2-T18b?/SnJ 000441 C3.JK-H2j H2-T18b/SnJ 000440 C3.LG-H2ar1/CkcCyJ 000439 C3.NB-H2p H2-T18c?/SnJ 000438 C3.SW-H2b/SnJ 000473 C3H-H2o2 C4bb/SfSnJ 001156 C57BL/6J-H2bm3/EgJ 001157 C57BL/6Kh-H2bm5/KhEgJ 000437 D1.C-H2d H2-T18c/SnJ 000436 D1.DA-H2qp1/SnJ 000435 D1.LP-H2b H2-T18b?/SnJ 000434 LP.RIII-H2r H2-T18b/SnJ 001383 LT.MA-Glo1b H2k/J 002591 NOD.B10Sn-H2b/J 006935 NOD.Cg-H2b thnh/J 004447 NOD.Cg-H2h4/DilTacUmmJ 001626 NOD.NON-H2nb1/LtJ 002032 NOD.SW-H2q/J 002974 STOCK Ces1ce H2d/J 001308 STOCK H2473a/J 003154 WLC.C-H2d/MorJ 003153 WLC.Cg-H2d Mtv2a/MorJ View Strains carrying other alleles of H2 (116 strains)
JAX® NOTES, Spring 1999; 477. Control Strains for NOD/LtJ Mice in Diabetes Research.
View Research Applications
Research Applications
This mouse can be used to support research in many areas including:
H2g7 relatedDiabetes and Obesity Research
Type 1 Diabetes (IDDM) Analysis Strains
NOD/ShiLtJ MHC Congenics
Immunology, Inflammation and Autoimmunity Research
CD Antigens, Antigen Receptors, and Histocompatibility Markers
| Allele Symbol | H2g7 | ||
|---|---|---|---|
| Allele Name | g7 variant | ||
| Allele Type | Not Applicable | ||
| Gene Symbol and Name | H2, histocompatibility-2, MHC | ||
| Chromosome | 17 | ||
| Gene Common Name(s) | H-2; MHC-II; | ||
| General Note | The g7 variant has been observed in the following strains: DBR7, NON.NOD-H2g7 | ||
H2g7 relatedAuger JL; Haasken S; Steinert EM; Binstadt BA. 2012. Incomplete TCR-beta allelic exclusion accelerates spontaneous autoimmune arthritis in K/BxN TCR transgenic mice. Eur J Immunol 42(9):2354-62. [PubMed: 22706882] [MGI Ref ID J:187944]
Belizaire R; Unanue ER. 2009. Targeting proteins to distinct subcellular compartments reveals unique requirements for MHC class I and II presentation. Proc Natl Acad Sci U S A 106(41):17463-8. [PubMed: 19805168] [MGI Ref ID J:153672]
Binstadt BA; Hebert JL; Ortiz-Lopez A; Bronson R; Benoist C; Mathis D. 2009. The same systemic autoimmune disease provokes arthritis and endocarditis via distinct mechanisms. Proc Natl Acad Sci U S A 106(39):16758-63. [PubMed: 19805369] [MGI Ref ID J:153217]
Carrasco-Marin E; Shimizu J; Kanagawa O; Unanue ER. 1996. The class II MHC I-Ag7 molecules from non-obese diabetic mice are poor peptide binders. J Immunol 156(2):450-8. [PubMed: 8543793] [MGI Ref ID J:30538]
Choisy-Rossi CM; Holl TM; Pierce MA; Chapman HD; Serreze DV. 2004. Enhanced pathogenicity of diabetogenic T cells escaping a non-MHC gene-controlled near death experience. J Immunol 173(6):3791-800. [PubMed: 15356126] [MGI Ref ID J:167508]
Driver JP; Chen YG; Zhang W; Asrat S; Serreze DV. 2011. Unmasking genes in a type 1 diabetes-resistant mouse strain that enhances pathogenic CD8 T-cell responses. Diabetes 60(4):1354-9. [PubMed: 21307079] [MGI Ref ID J:171763]
Driver JP; Scheuplein F; Chen YG; Grier AE; Wilson SB; Serreze DV. 2010. Invariant natural killer T-cell control of type 1 diabetes: a dendritic cell genetic decision of a silver bullet or Russian roulette. Diabetes 59(2):423-32. [PubMed: 19903740] [MGI Ref ID J:164162]
Ferreira C; Singh Y; Furmanski AL; Wong FS; Garden OA; Dyson J. 2009. Non-obese diabetic mice select a low-diversity repertoire of natural regulatory T cells. Proc Natl Acad Sci U S A 106(20):8320-5. [PubMed: 19359477] [MGI Ref ID J:148537]
Fossati G; Cooke A; Papafio RQ; Haskins K; Stockinger B. 1999. Triggering a second T cell receptor on diabetogenic T cells can prevent induction of diabetes. J Exp Med 190(4):577-83. [PubMed: 10449528] [MGI Ref ID J:108724]
Gray D; Abramson J; Benoist C; Mathis D. 2007. Proliferative arrest and rapid turnover of thymic epithelial cells expressing Aire. J Exp Med 204(11):2521-8. [PubMed: 17908938] [MGI Ref ID J:126040]
Jasinski JM; Yu L; Nakayama M; Li MM; Lipes MA; Eisenbarth GS; Liu E. 2006. Transgenic insulin (B:9-23) T-cell receptor mice develop autoimmune diabetes dependent upon RAG genotype, H-2g7 homozygosity, and insulin 2 gene knockout. Diabetes 55(7):1978-84. [PubMed: 16804066] [MGI Ref ID J:111874]
Klein J; Figueroa F; David CS. 1983. H-2 haplotypes, genes and antigens: second listing. II. The H-2 complex. Immunogenetics 17(6):553-96. [PubMed: 6407984] [MGI Ref ID J:7097]
Kouskoff V; Korganow AS; Duchatelle V; Degott C; Benoist C; Mathis D. 1996. Organ-specific disease provoked by systemic autoimmunity. Cell 87(5):811-22. [PubMed: 8945509] [MGI Ref ID J:36815]
Lee JS; Scandiuzzi L; Ray A; Wei J; Hofmeyer KA; Abadi YM; Loke P; Lin J; Yuan J; Serreze DV; Allison JP; Zang X. 2012. B7x in the periphery abrogates pancreas-specific damage mediated by self-reactive CD8 T cells. J Immunol 189(8):4165-74. [PubMed: 22972920] [MGI Ref ID J:190522]
Lee MS; Mueller R; Wicker LS; Peterson LB; Sarvetnick N. 1996. IL-10 is necessary and sufficient for autoimmune diabetes in conjunction with NOD MHC homozygosity. J Exp Med 183(6):2663-8. [PubMed: 8676087] [MGI Ref ID J:153576]
Leiter EH. 1998. NOD Mice and Related Strains: Origins, Husbandry and Biology Introduction. In: NOD Mice and Related Strains: Research Applications in Diabetes, AIDS, Cancer, and Other Diseases. RG Landes, Austin. [MGI Ref ID J:110093]
Levisetti MG; Lewis DM; Suri A; Unanue ER. 2008. Weak proinsulin peptide-major histocompatibility complexes are targeted in autoimmune diabetes in mice. Diabetes 57(7):1852-60. [PubMed: 18398138] [MGI Ref ID J:138230]
Luhder F; Katz J; Benoist C; Mathis D. 1998. Major histocompatibility complex class II molecules can protect from diabetes by positively selecting T cells with additional specificities. J Exp Med 187(3):379-87. [PubMed: 9449718] [MGI Ref ID J:108722]
Ma YD; Park C; Zhao H; Oduro KA Jr; Tu X; Long F; Allen PM; Teitelbaum SL; Choi K. 2009. Defects in osteoblast function but no changes in long-term repopulating potential of hematopoietic stem cells in a mouse chronic inflammatory arthritis model. Blood 114(20):4402-10. [PubMed: 19759358] [MGI Ref ID J:154922]
Mahler M; Bristol IJ; Leiter EH; Workman AE; Birkenmeier EH; Elson CO; Sundberg JP. 1998. Differential susceptibility of inbred mouse strains to dextran sulfate sodium-induced colitis. Am J Physiol 274(3 Pt 1):G544-51. [PubMed: 9530156] [MGI Ref ID J:46553]
Mangada J; Pearson T; Brehm MA; Wicker LS; Peterson LB; Shultz LD; Serreze DV; Rossini AA; Greiner DL. 2009. Idd loci synergize to prolong islet allograft survival induced by costimulation blockade in NOD mice. Diabetes 58(1):165-73. [PubMed: 18984741] [MGI Ref ID J:146982]
Martin-Orozco N; Chen Z; Poirot L; Hyatt E; Chen A; Kanagawa O; Sharpe A; Mathis D; Benoist C. 2003. Paradoxical dampening of anti-islet self-reactivity but promotion of diabetes by OX40 ligand. J Immunol 171(12):6954-60. [PubMed: 14662903] [MGI Ref ID J:86926]
Martinez RJ; Zhang N; Thomas SR; Nandiwada SL; Jenkins MK; Binstadt BA; Mueller DL. 2012. Arthritogenic self-reactive CD4+ T cells acquire an FR4hiCD73hi anergic state in the presence of Foxp3+ regulatory T cells. J Immunol 188(1):170-81. [PubMed: 22124124] [MGI Ref ID J:180819]
Pearson T; Markees TG; Serreze DV; Pierce MA; Marron MP; Wicker LS; Peterson LB; Shultz LD; Mordes JP; Rossini AA; Greiner DL. 2003. Genetic disassociation of autoimmunity and resistance to costimulation blockade-induced transplantation tolerance in nonobese diabetic mice. J Immunol 171(1):185-95. [PubMed: 12816997] [MGI Ref ID J:109845]
Podolin PL; Pressey A; DeLarato NH; Fischer PA; Peterson LB; Wicker LS. 1993. I-E+ nonobese diabetic mice develop insulitis and diabetes. J Exp Med 178(3):793-803. [PubMed: 8350054] [MGI Ref ID J:14178]
Serreze DV; Gallichan WS; Snider DP; Croitoru K; Rosenthal KL; Leiter EH; Christianson GJ; Dudley ME; Roopenian DC. 1996. MHC class I-mediated antigen presentation and induction of CD8+ cytotoxic T-cell responses in autoimmune diabetes-prone NOD mice. Diabetes 45(7):902-8. [PubMed: 8666141] [MGI Ref ID J:33688]
Suwanai H; Wilcox MA; Mathis D; Benoist C. 2010. A defective Il15 allele underlies the deficiency in natural killer cell activity in nonobese diabetic mice. Proc Natl Acad Sci U S A 107(20):9305-10. [PubMed: 20439722] [MGI Ref ID J:160284]
Taylor JJ; Martinez RJ; Titcombe PJ; Barsness LO; Thomas SR; Zhang N; Katzman SD; Jenkins MK; Mueller DL. 2012. Deletion and anergy of polyclonal B cells specific for ubiquitous membrane-bound self-antigen. J Exp Med 209(11):2065-77. [PubMed: 23071255] [MGI Ref ID J:190897]
Turley SJ; Lee JW; Dutton-Swain N; Mathis D; Benoist C. 2005. Endocrine self and gut non-self intersect in the pancreatic lymph nodes. Proc Natl Acad Sci U S A 102(49):17729-33. [PubMed: 16317068] [MGI Ref ID J:104385]
Victoratos P; Kollias G. 2009. Induction of autoantibody-mediated spontaneous arthritis critically depends on follicular dendritic cells. Immunity 30(1):130-42. [PubMed: 19119026] [MGI Ref ID J:143728]
Wang JX; Bair AM; King SL; Shnayder R; Huang YF; Shieh CC; Soberman RJ; Fuhlbrigge RC; Nigrovic PA. 2012. Ly6G ligation blocks recruitment of neutrophils via a beta2-integrin-dependent mechanism. Blood 120(7):1489-98. [PubMed: 22661700] [MGI Ref ID J:189105]
Wei J; Loke P; Zang X; Allison JP. 2011. Tissue-specific expression of B7x protects from CD4 T cell-mediated autoimmunity. J Exp Med 208(8):1683-94. [PubMed: 21727190] [MGI Ref ID J:177612]
Wong FS; Du W; Thomas IJ; Wen L. 2005. The influence of the major histocompatibility complex on development of autoimmune diabetes in RIP-B7.1 mice. Diabetes 54(7):2032-40. [PubMed: 15983204] [MGI Ref ID J:109830]
Yoshida T; Jiang F; Honjo T; Okazaki T. 2008. PD-1 deficiency reveals various tissue-specific autoimmunity by H-2b and dose-dependent requirement of H-2g7 for diabetes in NOD mice. Proc Natl Acad Sci U S A 105(9):3533-8. [PubMed: 18299579] [MGI Ref ID J:132764]
Zhang C; Todorov I; Lin CL; Atkinson M; Kandeel F; Forman S; Zeng D. 2007. Elimination of insulitis and augmentation of islet beta cell regeneration via induction of chimerism in overtly diabetic NOD mice. Proc Natl Acad Sci U S A 104(7):2337-42. [PubMed: 17267595] [MGI Ref ID J:119749]
This strain is currently Under Development for Cryo.
| Control | ||
|---|---|---|
| 002423 NON/ShiLtJ | ||
| Considerations for Choosing Controls | ||
| Control Pricing Information for Genetically Engineered Mutant Strains. | ||
| phone: | 207-288-6470 |
| fax: | 207-288-6655 |
MICE, PRODUCTS AND SERVICES ARE PROVIDED “AS IS”. JACKSON EXTENDS NO WARRANTIES OF ANY KIND, EITHER EXPRESS, IMPLIED, OR STATUTORY, WITH RESPECT TO MICE, PRODUCTS OR SERVICES, INCLUDING ANY IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, OR ANY WARRANTY OF NON-INFRINGEMENT OF ANY PATENT, TRADEMARK, OR OTHER INTELLECTUAL PROPERTY RIGHTS.
In case of dissatisfaction for a valid reason and claimed in writing by a purchaser within ninety (90) days of receipt of mice, products or services, JACKSON will, at its option, provide credit or replacement for the mice or product received or the services provided.
In no event shall JACKSON, its trustees, directors, officers, employees, and affiliates be liable for any causes of action or damages, including any direct, indirect, special, or consequential damages, arising out of the provision of MICE, PRODUCTS or services, including economic damage or injury to property and lost profits, and including any damage arising from acts or negligence on the part of JACKSON, its agents or employees. Unless prohibited by law, in purchasing or receiving MICE, PRODUCTS or services from JACKSON, purchaser or recipient, or any party claiming by or through them, expressly releases and discharges JACKSON from all such causes of action or damages, and further agrees to defend and indemnify JACKSON from any costs or damages arising out of any third party claims.
MICE and PRODUCTS are to be used in a safe manner and in accordance with all applicable governmental rules and regulations.
The foregoing represents the General Terms and Conditions applicable to JACKSON’s MICE, PRODUCTS or services. In addition, special terms and conditions of sale of certain MICE, PRODUCTS or services may be set forth separately in JACKSON web pages, catalogs, price lists, contracts, and/or other documents, and these special terms and conditions shall also govern the sale of these MICE, PRODUCTS and services by JACKSON, and by its licensees and distributors.
Acceptance of delivery of MICE, PRODUCTS or services shall be deemed agreement to these terms and conditions. No purchase order or other document transmitted by purchaser or recipient that may modify the terms and conditions hereof, shall be in any way binding on JACKSON, and instead the terms and conditions set forth herein, including any special terms and conditions set forth separately, shall govern the sale of MICE, PRODUCTS or services by JACKSON.